Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W, 2002. Assessment of azithromycin in combination with other anti-malarial drugs against plasmodium falciparum in vitro. Antimicrob Agents Chemother 46 :2518–2524.
-
2
Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, Patel K, Mohapatra MK, Lakhani J, Benner R, Lele C, Patki K, 2005. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis 191 :1582–1588.
-
3
Bray PG, Boulter MK, Ritchie GY, Howells RE, Ward SA, 1994. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Mol Biochem Parasitol 63 :87–94.
-
4
Pachot JI, Botham RP, Haegele KD, Hwang K, 2003. Experimental estimation of the role of p-glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the caco-2 cell model. J Pharm Pharm Sci 6 :1–12.
-
5
Kouznetsov RL, Beals PF, 1996. Malaria: A Manual for Community Health Workers. Geneva: World Health Organization, 31.
-
6
Zithromax. United States Package Insert. Pfizer, Inc. January Malaria: A Manual for Community Health Workers. Geneva: World Health Organization 2004.
-
7
Gustafsson LL, Walker O, Alván G, Beermann B, Estevez F, Gleisner L, Lindstrom B, Sjoqvist F, 1983. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15 :471–479.
-
8
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B, 1984. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26 :521–530.
-
9
Ofori-Adjei D, Ericsson O, Lindstrom B, Sjoqvist F, 1986. Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol 22 :356–358.
-
10
Augustijns P, Geusens P, Verbeke N, 1992. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol 42 :429–433.
-
11
Biswas S, 2001. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. J Postgrad Med 47 :240–243.
-
12
Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG, 1995. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med. 123 :771–773.
-
13
Gray RH, Wabwire-Mangen F, Kigozi G, Sewankambo NK, Serwadda D, Moulton LH, Quinn TC, O’Brien KL, Meehan M, Abramowsky C, Robb M, Wawer MJ, 2001. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 185 :1209–1217.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 824 | 686 | 53 |
| Full Text Views | 462 | 9 | 0 |
| PDF Downloads | 169 | 7 | 0 |
LACK OF A PHARMACOKINETIC INTERACTION BETWEEN AZITHROMYCIN AND CHLOROQUINE
JACK A. COOK
JACK A. COOK
Pfizer Global Research and Development, Pfizer Incorporated, Ann Arbor, Michigan
Search for other papers by JACK A. COOK in
Current site
Google Scholar
PubMed
Search for other papers by JACK A. COOK in
Current site
Google Scholar
PubMed
EDWARD J. RANDINITIS
EDWARD J. RANDINITIS
Pfizer Global Research and Development, Pfizer Incorporated, Ann Arbor, Michigan
Search for other papers by EDWARD J. RANDINITIS in
Current site
Google Scholar
PubMed
Search for other papers by EDWARD J. RANDINITIS in
Current site
Google Scholar
PubMed
CANDACE R. BRAMSON
CANDACE R. BRAMSON
Pfizer Global Research and Development, Pfizer Incorporated, Ann Arbor, Michigan
Search for other papers by CANDACE R. BRAMSON in
Current site
Google Scholar
PubMed
Search for other papers by CANDACE R. BRAMSON in
Current site
Google Scholar
PubMed
DAVID L. WESCHE
DAVID L. WESCHE
Pfizer Global Research and Development, Pfizer Incorporated, Ann Arbor, Michigan
Search for other papers by DAVID L. WESCHE in
Current site
Google Scholar
PubMed
Search for other papers by DAVID L. WESCHE in
Current site
Google Scholar
PubMed
A study was conducted to investigate a possible pharmacokinetic interaction between azithromycin and chloroquine. Twenty-four subjects received azithromycin, 1,000 mg a day for three days, followed by a washout period, then azithromycin, 1,000 mg plus chloroquine 600 mg base on days 1 and 2, and azithromycin, 1,000 mg plus chloroquine 300 mg base on day 3 of the final period. A second group of 16 subjects received chloroquine, 600 mg base on days 1 and 2, then 300 mg base on day 3. Blood samples were obtained serially up to 624 hours after the day 3 dose in each period. Log transformed maximum concentration and area under the curve values of azithromycin and chloroquine were compared using 90% confidence intervals calculated from appropriate analysis of variance models. Ninety percent confidence intervals for all pharmacokinetic parameters were contained within the interval 80–125%, which indicates the absence of a clinically relevant pharmacokinetic interaction.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W, 2002. Assessment of azithromycin in combination with other anti-malarial drugs against plasmodium falciparum in vitro. Antimicrob Agents Chemother 46 :2518–2524.
-
2
Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, Patel K, Mohapatra MK, Lakhani J, Benner R, Lele C, Patki K, 2005. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis 191 :1582–1588.
-
3
Bray PG, Boulter MK, Ritchie GY, Howells RE, Ward SA, 1994. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Mol Biochem Parasitol 63 :87–94.
-
4
Pachot JI, Botham RP, Haegele KD, Hwang K, 2003. Experimental estimation of the role of p-glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the caco-2 cell model. J Pharm Pharm Sci 6 :1–12.
-
5
Kouznetsov RL, Beals PF, 1996. Malaria: A Manual for Community Health Workers. Geneva: World Health Organization, 31.
-
6
Zithromax. United States Package Insert. Pfizer, Inc. January Malaria: A Manual for Community Health Workers. Geneva: World Health Organization 2004.
-
7
Gustafsson LL, Walker O, Alván G, Beermann B, Estevez F, Gleisner L, Lindstrom B, Sjoqvist F, 1983. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15 :471–479.
-
8
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B, 1984. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26 :521–530.
-
9
Ofori-Adjei D, Ericsson O, Lindstrom B, Sjoqvist F, 1986. Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol 22 :356–358.
-
10
Augustijns P, Geusens P, Verbeke N, 1992. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol 42 :429–433.
-
11
Biswas S, 2001. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. J Postgrad Med 47 :240–243.
-
12
Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG, 1995. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med. 123 :771–773.
-
13
Gray RH, Wabwire-Mangen F, Kigozi G, Sewankambo NK, Serwadda D, Moulton LH, Quinn TC, O’Brien KL, Meehan M, Abramowsky C, Robb M, Wawer MJ, 2001. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 185 :1209–1217.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 824 | 686 | 53 |
| Full Text Views | 462 | 9 | 0 |
| PDF Downloads | 169 | 7 | 0 |